Morning Edition

Monday - Friday 6am - 10am
Renee Montagne and Steve Inskeep

Waking up is hard to do, but it’s easier with NPR’s Morning Edition.  Hosts Renee Montagne and Steve Inskeep bring the day’s stories and news to radio listeners on the go. Morning Edition provides news in context, airs thoughtful ideas and commentary, and reviews important new music, books, and events in the arts.  All with voices and sounds that invite listeners to experience the stories.

The range of coverage includes reports on the Supreme Court from Nina Totenberg; education from Claudio Sanchez; health coverage from Joanne Silberner; and the latest on national security from Tom Gjelten. Steve and Renee interview newsmakers: from politicians, to academics, to filmmakers.  In-depth stories explore topics like “digital generations” about the effect of technology on the way we live; special series delve into the intersection of science and art, and find untold stories of the country’s Hidden Kitchens.

Morning Edition, it’s a world of ideas tailored to fit into your busy life.

Genre: 
Composer ID: 
5187f541e1c81793e5922773|5187f53be1c81793e592274e

Pages

It's All Politics
2:56 am
Wed May 29, 2013

Senators Tussle Over Proposal To 'Unpack' Key D.C. Court

Sen. Charles Grassley, R-Iowa, has proposed cutting three seats from a key D.C. appeals court.
Cliff Owen AP

Originally published on Wed May 29, 2013 10:47 am

More than 75 years ago, President Franklin Roosevelt caused an uproar with his plan to "pack" the Supreme Court with friendly justices. It was an audacious effort to protect his New Deal initiatives.

Now, Sen. Charles Grassley, R-Iowa, has floated the reverse — legislation that would cut three seats from the important D.C. Circuit appeals court, just as President Obama prepares to announce his nominees for those jobs.

The Court-Packing Plan

Read more
Sweetness And Light
10:03 pm
Tue May 28, 2013

One More Swing: 'Casey At The Bat'

Paul Sancya AP

Originally published on Wed May 29, 2013 11:03 am

Frank Deford puts aside his gripes this week to pay tribute to the poem by Ernest Lawrence Thayer, first published in the San Francisco Examiner 125 years ago June 3.

The Outlook wasn't brilliant for the Mudville nine that day:
The score stood four to two, with but one inning more to play.
And then when Cooney died at first, and Barrows did the same,
A sickly silence fell upon the patrons of the game.

Read more
Around the Nation
7:26 am
Tue May 28, 2013

New York's Bike Share Program Off To A Bumpy Start

Originally published on Tue May 28, 2013 7:59 am

Transcript

DAVID GREENE, HOST:

Good morning. I'm David Greene. After much anticipation, New York City has kicked off its bike share program. Riders can pick up a bike, take a ride and return it to a different spot. So far it's been a bumpy ride. About a hundred keys that members use to unlock bikes were lost in the mail. And, as workers were loading the $825 bikes in for the first day of service this week, someone snagged one and rode off.

Business
7:13 am
Tue May 28, 2013

What's That Smell? Pancakes Or Canadian $100 Bills

Originally published on Tue May 28, 2013 7:59 am

Transcript

RENEE MONTAGNE, HOST:

Good morning, I'm Renee Montagne.

We all know pancakes are best when slathered with maple syrup. But cash? The Bank of Canada is denying it's given its new plastic $100 bills a syrup scent. The rumor is that the new bills contain a scratch-and-sniff section. The Canadian press obtained a bunch of emails to the bank about the fabled edition of the maple syrup. One complained the notes stick together. Another lamented that some had lost their smell.

It's MORNING EDITION. Transcript provided by NPR, Copyright NPR.

Business
4:53 am
Tue May 28, 2013

Business News

Originally published on Tue May 28, 2013 7:58 am

Transcript

DAVID GREENE, HOST:

NPR's business news starts with corporate sell-offs.

(SOUNDBITE OF MUSIC)

GREENE: Bausch + Lomb has been sold. The drug maker Valeant Pharmaceuticals is buying the 160-year-old eye care company for $8.7 billion.

RENEE MONTAGNE, HOST:

Valeant - which is a Canadian company - has been on a buying spree recently, as it moves to become a bigger player in the global pharmaceutical market.

Read more

Pages